The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD
Weifang Huang, Desong Kong
Abstract
INTRODUCTION: Liver diseases are currently common disorders worldwide. Especially, the proportion of patients with nonalcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) is growing globally. An increasing number of studies have revealed a close relationship between the intestinal microbiota and the development of NAFLD and ALD. A better understanding of the role of intestinal microbiota and the intestine-liver axis thus might lead to the development novel therapies for the treatment of these diseases.
Topics & Concepts
Nonalcoholic fatty liver diseaseFatty liverMedicineGastroenterologyGut floraDiseaseInternal medicineLiver diseaseAlcoholic liver diseaseImmunologyCirrhosisLiver Disease Diagnosis and TreatmentGut microbiota and healthDiet, Metabolism, and Disease